TLT8
TLT8 is a ByeTAC protein degrader targeting BTK. TLT8 non-covalently binds to Rpn-13 and BTK, thereby inducing BTK degradation. TLT8 can be used in chronic lymphocytic leukemia research. (Rpn-13 ligand: HY-159808; BTK ligand: HY-Z3101; linker: HY-172823).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C63H76BrClN12O12S
- Masse moléculaire:1340.77
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Chemical Information
-
Masse moléculaire 1340.77
-
Formule C63H76BrClN12O12S
-
SMILES
NC1=C2C(C3=CC=C(C=C3)OC4=CC=CC=C4)=NN(C2=NC=N1)[C@H]5CCCN(C5)C(CCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCNC(CC6SC7=NN=C(N7N=C6C8=CC=C(C=C8)Cl)CC9=CC=C(C=C9)Br)=O)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
TLT8 Related Classifications
HY-172822 Related Classifications
Powered by Bioz